Reporting side effects: If you experience a suspected side effect from any medicine, including investigational treatments received within a clinical trial, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Akasov, R
The activation of GLP-1R can reduce the size of cerebral infarction by enhancing cell survival signaling pathways, reducing ischemia-reperfusion injury, promoting brain repair, and inhibiting inflammatory response and oxidative stress ( 4.4 Tumors The role of GLP-1RA in tumor remains controversial
Inform your healthcare provider about any other medications, herbal products, or vitamin/mineral supplements you are currently taking
Data on file, Rigel Pharmaceuticals, Inc
These head-to-head trials will provide important comparative data for clinical decision-making as the pipeline continues to mature